The overall objective of this study is to determine whether very early antiretroviral
treatment (ART) initiation in HIV-infected infants limits the seeding of viral reservoirs and
maintains immune responses, potentially allowing future periods off ART.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Harvard School of Public Health Harvard School of Public Health (HSPH)
Collaborators:
Brigham and Women's Hospital Ragon Institute of MGH, MIT and Harvard University of California, San Diego